Patents (1436 Stem Cell Patents)

Class: Expansion (424)

Order by:
<< | < | 31 32 33 34 35 36 37 38 39 | > | >>


Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines

Patent Number: 5997860

This patent covers IL-3 and various deviations of it, in combination with other hematopoietic stem cell stimulatory cytokines for acceleration of hematopoietic recovery after stem cell transplantation. This patent is useful in situations in which the stem cell dose administered may be relatively low, such as cord blood transplants given to adult recipients.

Inventors: Bauer, S. Christopher (New Haven, MO); Abrams, Mark Allen (St. Louis, MO); Braford-Goldberg, Sarah Ruth (St. Louis, MO); Caparon, Maire Helena (Chesterfield, MO); Easton, Alan Michael (Maryland Heights, MO); Klein, Barbara Kure (St. Louis, MO); McKearn, J
Assignee: G. D. Searle & Co. (Chicago, IL)
Date of First Priority Issue: Tuesday November 24th, 1992

Method for regulating neuron development and maintenance

Patent Number: 7,173,001

Leukemia inhibitory factor (LIF) is a member of the IL-6 family of cytokines that was originally identified based on its ability to induce differentiation of myeloid leukemia cells. Its homology ciliary neurotrophic factor (CNTF) has been shown to support the resistance to apoptosis of numerous types of peripheral and central nervous system neurons, as well as induce new neurite formation...

Inventors: Bartlett; Perry (North Carlton, AU), Murphy; Mark (Fitzroy, AU)
Assignee: Zenyth Operations Pty Ltd. (Richmond, AU)
Date of First Priority Issue: Thursday November 19th, 1992

Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides

Patent Number: 6051217

This patent provides compositions of matter for various forms of the cytokine IL-3. Uses of IL-3 such as stimulation of hematopoiesis are described. Since myeloid suppressor cells express the IL-3 receptor, it may be interesting to see if IL-3 can actually mediate immune suppressive functions.

Inventors: Bauer, S. Christopher (New Haven, MO); Abrams, Mark Allen (St. Louis, MO); Braford-Goldberg, Sarah Ruth (St. Louis, MO); Caparon, Maire Helena (Chesterfield, MO); Easton, Alan Michael (Maryland Heights, MO); Klein, Barbara Kure (St. Louis, MO); McKearn, J
Assignee: G. D. Searle & Co. (Chicago, IL)
Date of First Priority Issue: Saturday November 14th, 1992

Method of enhancing the growth of gut epithelial cells by administration of a cytokine such as interleukin II

Patent Number: 5437863

Gut epithelial cells are proliferating, well at least the stem cells that give rise to them, are in a state of constant proliferation. This is one of the reasons why after chemotherapy and/or radiation therapy, there is adverse effects associated with the GI tract. This patent teaches that proliferation of these cells can be stimulated by IL-6, IL-11, LIF, Oncostatin...

Inventors: Williams, David A. (Indianapolis, IN); Clark, Steven C. (Winchester, MA)
Assignee: Genetics Institute, Inc. (Cambridge, MA)
Date of First Priority Issue: Wednesday September 2nd, 1992

Culture of totipotent embryonic inner cells mass cells and production of bovine animals

Patent Number: 6107543

This patent is about ways of cloning cows using stem cells harvested form the inner cell mass.

Inventors: Sims, Michelle M. (Stoughton, WI); First, Neal L. (Madison, WI)
Assignee: Infigen, Inc. (DeForest, WI)
Date of First Priority Issue: Thursday August 20th, 1992

Single chain peptide compounds having hemoregulatory activity

Patent Number: 5629293

This is a composition of matter patent on a peptide that has stimulatory activity to stem cells of the hematopoietic system. This patent can be used for not only stimulating hematopoiesis in a patient, but also for other novel uses such as angiogenesis.

Inventors: Undheim, Kjell (Sandvika, NO); Kremminger, Peter (Liuz, AT); Hartmann, Michael (Pettenbach, AT)
Assignee: Nycomed Imaging AS (Oslo, NO)
Date of First Priority Issue: Tuesday June 2nd, 1992

Double chain peptide compounds having hemoregulatory activity

Patent Number: 5610141

This patent is a composition of matter patent covering a novel peptide that has ability to stimulate bone marrow proliferation and hematopoiesis. This is a very useful patent for pharmaceutical development since there is a need in the art for agents with good pharmacokinetics that stimulate hematopoiesis.

Inventors: Undheim, Kjell (Sandvika, NO); Solbakken, Magne (Oslo, NO); Agner, Erik (Oslo, NO); Kremminger, Peter (Linz, AT); Lange, Meinolf (Oslo, NO)
Assignee: Nycomed Imaging AS (NO)
Date of First Priority Issue: Tuesday June 2nd, 1992

Methods and reagents for lengthening telomeres

Patent Number: 5686306

This patent provides compositions of matter, specifically peptide targets for telomerase, which allow for enhanced telomerase activity and longer cellular life span.

Inventors: West, Michael D. (San Carlos, CA); Shay, Jerry (Dallas, TX); Wright, Woodring E. (Arlington, TX)
Assignee: Board of Regents, The University of Texas System (Austin, TX)
Date of First Priority Issue: Wednesday May 13th, 1992

Use of c-kit ligand with TNF-.alpha. and hematopoietic factors for the expansion or differentiation of hematopoietic cells

Patent Number: 6159461

Combinations of cytokines are provided in this patent for expanding the number of hematopoietic stem cells. Cytokines include stem cell factor, tnf-alpha, and pixy. This is somewhat interesting since TNF alpha is usually considered to inhibit hematopoiesis.

Inventors: Besmer, Peter (New York, NY); Buck, Jochen (New York, NY); Moore, Malcolm A. S. (New York, NY); Nocka, Karl (Harvard, MA)
Assignee: Sloan-Kettering Institute for Cancer Research (New York, NY)
Date of First Priority Issue: Thursday April 23rd, 1992

Method for culturing hematopoietic cells

Patent Number: 5460964

This patent teaches the culture of hematopoietic stem cells in a manner that the cells do not adhere to the stromal cells that provide various trophic growth factors. IL-3 and MIP-1 alpha are also covered for use in the hematopoietic stem cell culture system described herein.

Inventors: McGlave, Philip B. (St. Paul, MN); Verfaillie, Catherine M. (St. Paul, MN); Miller, Jeffrey S. (Little Canada, MN)
Assignee: Regents of the University of Minnesota (Minneapolis, MN)
Date of First Priority Issue: Friday April 3rd, 1992

Order by:
<< | < | 31 32 33 34 35 36 37 38 39 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent